Pharmaceutical firms vow to defy government’s drug pricing reform

Asserting that the government’s “ill-conceived” plan, which was announced Monday, would shake the pharmaceutical industry to its roots, Korea Pharmaceutical Manufacturers Association (KPMA) pledged joint efforts to block it from being implemented.

The move, designed to reduce national health insurance expenditures, left pharmaceutical companies vowing to resist the measure, which they said ...